362 related articles for article (PubMed ID: 32461927)
1. Patient-derived xenografts as compatible models for precision oncology.
Cho SY
Lab Anim Res; 2020; 36():14. PubMed ID: 32461927
[TBL] [Abstract][Full Text] [Related]
2. Patient-derived xenograft platform of OSCC: a renewable human bio-bank for preclinical cancer research and a new co-clinical model for treatment optimization.
Sun S; Zhang Z
Front Med; 2016 Mar; 10(1):104-10. PubMed ID: 26926009
[TBL] [Abstract][Full Text] [Related]
3. Patient-Derived Xenograft Models in Urological Malignancies: Urothelial Cell Carcinoma and Renal Cell Carcinoma.
Tracey AT; Murray KS; Coleman JA; Kim K
Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32069881
[TBL] [Abstract][Full Text] [Related]
4. Establishment of a high-fidelity patient-derived xenograft model for cervical cancer enables the evaluation of patient's response to conventional and novel therapies.
Liu L; Wu M; Huang A; Gao C; Yang Y; Liu H; Jiang H; Yu L; Huang Y; Wang H
J Transl Med; 2023 Sep; 21(1):611. PubMed ID: 37689699
[TBL] [Abstract][Full Text] [Related]
5. The chick chorioallantoic membrane (CAM) as a versatile patient-derived xenograft (PDX) platform for precision medicine and preclinical research.
DeBord LC; Pathak RR; Villaneuva M; Liu HC; Harrington DA; Yu W; Lewis MT; Sikora AG
Am J Cancer Res; 2018; 8(8):1642-1660. PubMed ID: 30210932
[TBL] [Abstract][Full Text] [Related]
6. A large collection of integrated genomically characterized patient-derived xenografts highlighting the heterogeneity of triple-negative breast cancer.
Coussy F; de Koning L; Lavigne M; Bernard V; Ouine B; Boulai A; El Botty R; Dahmani A; Montaudon E; Assayag F; Morisset L; Huguet L; Sourd L; Painsec P; Callens C; Chateau-Joubert S; Servely JL; Larcher T; Reyes C; Girard E; Pierron G; Laurent C; Vacher S; Baulande S; Melaabi S; Vincent-Salomon A; Gentien D; Dieras V; Bieche I; Marangoni E
Int J Cancer; 2019 Oct; 145(7):1902-1912. PubMed ID: 30859564
[TBL] [Abstract][Full Text] [Related]
7. Characterization of drug responses of mini patient-derived xenografts in mice for predicting cancer patient clinical therapeutic response.
Zhang F; Wang W; Long Y; Liu H; Cheng J; Guo L; Li R; Meng C; Yu S; Zhao Q; Lu S; Wang L; Wang H; Wen D
Cancer Commun (Lond); 2018 Sep; 38(1):60. PubMed ID: 30257718
[TBL] [Abstract][Full Text] [Related]
8. Current Update of Patient-Derived Xenograft Model for Translational Breast Cancer Research.
Kawaguchi T; Foster BA; Young J; Takabe K
J Mammary Gland Biol Neoplasia; 2017 Jun; 22(2):131-139. PubMed ID: 28451789
[TBL] [Abstract][Full Text] [Related]
9. Applications of patient-derived tumor xenograft models and tumor organoids.
Yoshida GJ
J Hematol Oncol; 2020 Jan; 13(1):4. PubMed ID: 31910904
[TBL] [Abstract][Full Text] [Related]
10. Patient Characteristics Associated with Growth of Patient-Derived Tumor Implants in Mice (Patient-Derived Xenografts).
Hernández Guerrero T; Baños N; Del Puerto Nevado L; Mahillo-Fernandez I; Doger De-Speville B; Calvo E; Wick M; García-Foncillas J; Moreno V
Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001663
[No Abstract] [Full Text] [Related]
11. Patient-derived xenograft (PDX) models: characteristics and points to consider for the process of establishment.
Fujii E; Kato A; Suzuki M
J Toxicol Pathol; 2020 Jul; 33(3):153-160. PubMed ID: 32764840
[TBL] [Abstract][Full Text] [Related]
12. Patient-derived xenograft models to improve targeted therapy in epithelial ovarian cancer treatment.
Scott CL; Becker MA; Haluska P; Samimi G
Front Oncol; 2013 Dec; 3():295. PubMed ID: 24363999
[TBL] [Abstract][Full Text] [Related]
13. Patient-Derived Tumor Xenograft Models: Toward the Establishment of Precision Cancer Medicine.
Goto T
J Pers Med; 2020 Jul; 10(3):. PubMed ID: 32708458
[TBL] [Abstract][Full Text] [Related]
14. The Generation and Application of Patient-Derived Xenograft Model for Cancer Research.
Jung J; Seol HS; Chang S
Cancer Res Treat; 2018 Jan; 50(1):1-10. PubMed ID: 28903551
[TBL] [Abstract][Full Text] [Related]
15. Generation, evolution, interfering factors, applications, and challenges of patient-derived xenograft models in immunodeficient mice.
Zeng M; Ruan Z; Tang J; Liu M; Hu C; Fan P; Dai X
Cancer Cell Int; 2023 Jun; 23(1):120. PubMed ID: 37344821
[TBL] [Abstract][Full Text] [Related]
16. Current and Future Horizons of Patient-Derived Xenograft Models in Colorectal Cancer Translational Research.
Inoue A; Deem AK; Kopetz S; Heffernan TP; Draetta GF; Carugo A
Cancers (Basel); 2019 Sep; 11(9):. PubMed ID: 31500168
[TBL] [Abstract][Full Text] [Related]
17. Establishment of a Patient-Derived Tumor Xenograft Model and Application for Precision Cancer Medicine.
Okada S; Vaeteewoottacharn K; Kariya R
Chem Pharm Bull (Tokyo); 2018; 66(3):225-230. PubMed ID: 29491256
[TBL] [Abstract][Full Text] [Related]
18. Patient-derived xenograft models for personalized medicine in colorectal cancer.
Xie J; Lin Y
Clin Exp Med; 2020 May; 20(2):167-172. PubMed ID: 32100151
[TBL] [Abstract][Full Text] [Related]
19. The Application of Patient-Derived Xenograft Models in Gynecologic Cancers.
Jiang W; Xie S; Liu Y; Zou S; Zhu X
J Cancer; 2020; 11(18):5478-5489. PubMed ID: 32742495
[TBL] [Abstract][Full Text] [Related]
20. Patient-Derived Xenograft Models of Non-Small Cell Lung Cancer and Their Potential Utility in Personalized Medicine.
Morgan KM; Riedlinger GM; Rosenfeld J; Ganesan S; Pine SR
Front Oncol; 2017; 7():2. PubMed ID: 28154808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
